Hypopharyngeal Cancer Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 62 pages | ID: H9B7DE21438DEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hypopharyngeal Cancer Treatment in Global, including the following market information:

Global Hypopharyngeal Cancer Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hypopharyngeal Cancer Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Ganetespib Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hypopharyngeal Cancer Treatment include Celldex Therapeutics Inc, Incyte Corp, Madrigal Pharmaceuticals Inc. and Merck & Co Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypopharyngeal Cancer Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hypopharyngeal Cancer Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hypopharyngeal Cancer Treatment Market Segment Percentages, by Type, 2021 (%)

• Ganetespib
• PGV-001
• Nimotuzumab
• CDX-3379
• Others

Global Hypopharyngeal Cancer Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hypopharyngeal Cancer Treatment Market Segment Percentages, by Application, 2021 (%)

• Out-Patient
• In-Patient

Global Hypopharyngeal Cancer Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hypopharyngeal Cancer Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hypopharyngeal Cancer Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hypopharyngeal Cancer Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Celldex Therapeutics Inc
• Incyte Corp
• Madrigal Pharmaceuticals Inc.
• Merck & Co Inc

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hypopharyngeal Cancer Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hypopharyngeal Cancer Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYPOPHARYNGEAL CANCER TREATMENT OVERALL MARKET SIZE

2.1 Global Hypopharyngeal Cancer Treatment Market Size: 2021 VS 2028
2.2 Global Hypopharyngeal Cancer Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hypopharyngeal Cancer Treatment Players in Global Market
3.2 Top Global Hypopharyngeal Cancer Treatment Companies Ranked by Revenue
3.3 Global Hypopharyngeal Cancer Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hypopharyngeal Cancer Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hypopharyngeal Cancer Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypopharyngeal Cancer Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hypopharyngeal Cancer Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hypopharyngeal Cancer Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hypopharyngeal Cancer Treatment Market Size Markets, 2021 & 2028
  4.1.2 Ganetespib
  4.1.3 PGV-001
  4.1.4 Nimotuzumab
  4.1.5 CDX-3379
  4.1.6 Others
4.2 By Type - Global Hypopharyngeal Cancer Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hypopharyngeal Cancer Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hypopharyngeal Cancer Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hypopharyngeal Cancer Treatment Market Size, 2021 & 2028
  5.1.2 Out-Patient
  5.1.3 In-Patient
5.2 By Application - Global Hypopharyngeal Cancer Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hypopharyngeal Cancer Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hypopharyngeal Cancer Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hypopharyngeal Cancer Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hypopharyngeal Cancer Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hypopharyngeal Cancer Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hypopharyngeal Cancer Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hypopharyngeal Cancer Treatment Revenue, 2017-2028
  6.3.2 US Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.3.3 Canada Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.3.4 Mexico Hypopharyngeal Cancer Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hypopharyngeal Cancer Treatment Revenue, 2017-2028
  6.4.2 Germany Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.4.3 France Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.4.4 U.K. Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.4.5 Italy Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.4.6 Russia Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.4.8 Benelux Hypopharyngeal Cancer Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hypopharyngeal Cancer Treatment Revenue, 2017-2028
  6.5.2 China Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.5.3 Japan Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.5.4 South Korea Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.5.6 India Hypopharyngeal Cancer Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hypopharyngeal Cancer Treatment Revenue, 2017-2028
  6.6.2 Brazil Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.6.3 Argentina Hypopharyngeal Cancer Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hypopharyngeal Cancer Treatment Revenue, 2017-2028
  6.7.2 Turkey Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.7.3 Israel Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hypopharyngeal Cancer Treatment Market Size, 2017-2028
  6.7.5 UAE Hypopharyngeal Cancer Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Celldex Therapeutics Inc
  7.1.1 Celldex Therapeutics Inc Corporate Summary
  7.1.2 Celldex Therapeutics Inc Business Overview
  7.1.3 Celldex Therapeutics Inc Hypopharyngeal Cancer Treatment Major Product Offerings
  7.1.4 Celldex Therapeutics Inc Hypopharyngeal Cancer Treatment Revenue in Global Market (2017-2022)
  7.1.5 Celldex Therapeutics Inc Key News
7.2 Incyte Corp
  7.2.1 Incyte Corp Corporate Summary
  7.2.2 Incyte Corp Business Overview
  7.2.3 Incyte Corp Hypopharyngeal Cancer Treatment Major Product Offerings
  7.2.4 Incyte Corp Hypopharyngeal Cancer Treatment Revenue in Global Market (2017-2022)
  7.2.5 Incyte Corp Key News
7.3 Madrigal Pharmaceuticals Inc.
  7.3.1 Madrigal Pharmaceuticals Inc. Corporate Summary
  7.3.2 Madrigal Pharmaceuticals Inc. Business Overview
  7.3.3 Madrigal Pharmaceuticals Inc. Hypopharyngeal Cancer Treatment Major Product Offerings
  7.3.4 Madrigal Pharmaceuticals Inc. Hypopharyngeal Cancer Treatment Revenue in Global Market (2017-2022)
  7.3.5 Madrigal Pharmaceuticals Inc. Key News
7.4 Merck & Co Inc
  7.4.1 Merck & Co Inc Corporate Summary
  7.4.2 Merck & Co Inc Business Overview
  7.4.3 Merck & Co Inc Hypopharyngeal Cancer Treatment Major Product Offerings
  7.4.4 Merck & Co Inc Hypopharyngeal Cancer Treatment Revenue in Global Market (2017-2022)
  7.4.5 Merck & Co Inc Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hypopharyngeal Cancer Treatment Market Opportunities & Trends in Global Market
Table 2. Hypopharyngeal Cancer Treatment Market Drivers in Global Market
Table 3. Hypopharyngeal Cancer Treatment Market Restraints in Global Market
Table 4. Key Players of Hypopharyngeal Cancer Treatment in Global Market
Table 5. Top Hypopharyngeal Cancer Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hypopharyngeal Cancer Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hypopharyngeal Cancer Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hypopharyngeal Cancer Treatment Product Type
Table 9. List of Global Tier 1 Hypopharyngeal Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypopharyngeal Cancer Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hypopharyngeal Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hypopharyngeal Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hypopharyngeal Cancer Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hypopharyngeal Cancer Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hypopharyngeal Cancer Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hypopharyngeal Cancer Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Celldex Therapeutics Inc Corporate Summary
Table 31. Celldex Therapeutics Inc Hypopharyngeal Cancer Treatment Product Offerings
Table 32. Celldex Therapeutics Inc Hypopharyngeal Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Incyte Corp Corporate Summary
Table 34. Incyte Corp Hypopharyngeal Cancer Treatment Product Offerings
Table 35. Incyte Corp Hypopharyngeal Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Madrigal Pharmaceuticals Inc. Corporate Summary
Table 37. Madrigal Pharmaceuticals Inc. Hypopharyngeal Cancer Treatment Product Offerings
Table 38. Madrigal Pharmaceuticals Inc. Hypopharyngeal Cancer Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Merck & Co Inc Corporate Summary
Table 40. Merck & Co Inc Hypopharyngeal Cancer Treatment Product Offerings
Table 41. Merck & Co Inc Hypopharyngeal Cancer Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hypopharyngeal Cancer Treatment Segment by Type in 2021
Figure 2. Hypopharyngeal Cancer Treatment Segment by Application in 2021
Figure 3. Global Hypopharyngeal Cancer Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hypopharyngeal Cancer Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hypopharyngeal Cancer Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hypopharyngeal Cancer Treatment Revenue in 2021
Figure 8. By Type - Global Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 12. US Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 24. China Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hypopharyngeal Cancer Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hypopharyngeal Cancer Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Celldex Therapeutics Inc Hypopharyngeal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Incyte Corp Hypopharyngeal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Madrigal Pharmaceuticals Inc. Hypopharyngeal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck & Co Inc Hypopharyngeal Cancer Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)